Health-related quality of life in young survivors of childhood cancer
L Wengenroth, M E Gianinazzi, C S Rueegg, S Lüer, E Bergstraesser, C E Kuehni, G Michel, L Wengenroth, M E Gianinazzi, C S Rueegg, S Lüer, E Bergstraesser, C E Kuehni, G Michel
Abstract
Purpose: Childhood cancer and its treatment may affect health-related quality of life (HRQoL) in childhood cancer survivors, but population-based studies in young survivors are scarce. We aimed to: (1) compare HRQoL between young survivors and population norms and (2) find factors that influence parent-reported HRQoL in survivors.
Methods: As part of the Swiss Childhood Cancer Survivor Study, a questionnaire was mailed to parents of survivors aged 8-16 years, registered in the Swiss Childhood Cancer Registry, ≥5 years after diagnosis. We used the KIDSCREEN-27 instrument to compare self- and parent-reported HRQoL between survivors (N = 425) and standardized norms in the five dimensions of physical well-being, psychological well-being, autonomy, peers and school environment (mean = 50, SD = 10). We then used multivariable linear regressions to test the influence of socio-demographic and cancer-related factors on HRQoL.
Results: Self-reported physical well-being was comparable to norms. Other HRQoL dimensions were higher than norms, with the highest mean = 52.2 (p < 0.001) for school environment. Parent-reported HRQoL in survivors was comparable to population norms; only physical well-being was lower (mean = 47.1, p < 0.001), and school environment was higher (mean = 51.1, p = 0.035). Parent-reported HRQoL was lower for survivors of CNS tumors (physical well-being: β = -5.27, p = 0.007; psychological well-being: β = -4.39, p = 0.044; peers β = -5.17, p = 0.028), survivors of neuroblastoma (psychological well-being β = -5.20, p = 0.047), and survivors who had had a relapse (physical well-being β = -5.41, p = 0.005).
Conclusions: Assessing HRQoL during follow-up care, with a focus on physical well-being, specific diagnoses (e.g., CNS tumor) and late complications (e.g., relapse) might help to early identify problems and offer support to survivors with reduced HRQoL.
References
- Pediatr Blood Cancer. 2011 Apr;56(4):646-53
- J Cancer Surviv. 2013 Dec;7(4):511-22
- JAMA. 2003 Sep 24;290(12):1583-92
- Pediatr Blood Cancer. 2008 May;50(5):1018-25
- Child Neuropsychol. 2008 Jul;14 (4):323-38
- Eur J Cancer. 2009 Apr;45(6):992-1005
- Health Qual Life Outcomes. 2007 Dec 03;5:65
- Child Care Health Dev. 2003 Mar;29(2):95-102
- Qual Life Res. 2014 Nov;23(9):2603-12
- Cancer. 2005 Oct 15;104(8):1751-60
- Lancet. 2007 Jun 30;369(9580):2171-2178
- Int J Epidemiol. 2012 Dec;41(6):1553-64
- PLoS One. 2012;7(5):e38015
- Psychooncology. 2014 Mar;23(3):266-75
- Pediatr Blood Cancer. 2006 Sep;47(3):312-9
- Pediatrics. 2007 Nov;120(5):e1229-36
- Acta Oncol. 2014 Apr;53(4):486-92
- N Engl J Med. 2006 Oct 12;355(15):1572-82
- Swiss Med Wkly. 2007 Sep 8;137(35-36):502-9
- Qual Life Res. 2007 Oct;16(8):1347-56
- CA Cancer J Clin. 2013 Jan;63(1):11-30
- Qual Life Res. 2012 Nov;21(9):1577-86
- Int J Cancer. 2007 Aug 1;121(3):633-40
- Pediatr Blood Cancer. 2007 Oct 15;49(5):704-15
- Support Care Cancer. 2005 Jan;13(1):49-56
- Cancer. 2002 Apr 1;94(7):2090-106
- Qual Life Res. 2007 Oct;16(8):1335-45
- J Clin Oncol. 2015 Feb 10;33(5):479-91
- Pediatr Blood Cancer. 2014 Oct;61(10):1891-4
- J Clin Oncol. 2005 Aug 20;23(24):5493-500
- Brain Inj. 2012;26(3):270-81
- Soc Psychiatry Psychiatr Epidemiol. 2013 Mar;48(3):503-11
- Health Qual Life Outcomes. 2013 Jun 13;11:96
- Eur J Oncol Nurs. 2008 Jul;12(3):209-16
- Qual Life Res. 2009 Nov;18(9):1147-57
- BMC Public Health. 2014 Aug 03;14:790
- Cancer. 2005 Apr 1;103(7):1457-67
- J Clin Oncol. 2009 May 10;27(14):2308-18
- Pediatr Transplant. 2010 Mar;14(2):216-23
- Qual Life Res. 2007 Jun;16(5):863-71
- Br J Cancer. 2009 Jan 13;100(1):82-8
- J Rehabil Med. 2011 Jun;43(7):584-9
- PLoS One. 2012;7(10):e47944
- Eur J Cancer. 2007 Nov;43(17):2545-52
Source: PubMed